BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34695425)

  • 1. Rab7 reduces α-synuclein toxicity in rats and primary neurons.
    Szegö EM; Van den Haute C; Höfs L; Baekelandt V; Van der Perren A; Falkenburger BH
    Exp Neurol; 2022 Jan; 347():113900. PubMed ID: 34695425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity.
    Hu D; Sun X; Liao X; Zhang X; Zarabi S; Schimmer A; Hong Y; Ford C; Luo Y; Qi X
    Acta Neuropathol; 2019 Jun; 137(6):939-960. PubMed ID: 30877431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
    Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
    Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons.
    Koch JC; Bitow F; Haack J; d'Hedouville Z; Zhang JN; Tönges L; Michel U; Oliveira LM; Jovin TM; Liman J; Tatenhorst L; Bähr M; Lingor P
    Cell Death Dis; 2015 Jul; 6(7):e1811. PubMed ID: 26158517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
    Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
    Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rab7 induces clearance of α-synuclein aggregates.
    Dinter E; Saridaki T; Nippold M; Plum S; Diederichs L; Komnig D; Fensky L; May C; Marcus K; Voigt A; Schulz JB; Falkenburger BH
    J Neurochem; 2016 Sep; 138(5):758-74. PubMed ID: 27333324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
    Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
    Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of α-synuclein propagation after intrastriatal injection in FABP3 null mice.
    Matsuo K; Kawahata I; Melki R; Bousset L; Owada Y; Fukunaga K
    Brain Res; 2021 Jun; 1760():147383. PubMed ID: 33636166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.
    Boi L; Pisanu A; Palmas MF; Fusco G; Carboni E; Casu MA; Satta V; Scherma M; Janda E; Mocci I; Mulas G; Ena A; Spiga S; Fadda P; De Simone A; Carta AR
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NADPH oxidase 1 mediates α-synucleinopathy in Parkinson's disease.
    Cristóvão AC; Guhathakurta S; Bok E; Je G; Yoo SD; Choi DH; Kim YS
    J Neurosci; 2012 Oct; 32(42):14465-77. PubMed ID: 23077033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal activity modulates alpha-synuclein aggregation and spreading in organotypic brain slice cultures and in vivo.
    Wu Q; Shaikh MA; Meymand ES; Zhang B; Luk KC; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2020 Dec; 140(6):831-849. PubMed ID: 33021680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome release and neuropathology induced by α-synuclein: new insights into protective mechanisms of Drp1 inhibition.
    Fan RZ; Guo M; Luo S; Cui M; Tieu K
    Acta Neuropathol Commun; 2019 Nov; 7(1):184. PubMed ID: 31744532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sigma-1 receptor knockout increases α-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra.
    Hong J; Wang L; Zhang T; Zhang B; Chen L
    Neurobiol Aging; 2017 Nov; 59():171-183. PubMed ID: 28870519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.
    García-Revilla J; Boza-Serrano A; Jin Y; Vadukul DM; Soldán-Hidalgo J; Camprubí-Ferrer L; García-Cruzado M; Martinsson I; Klementieva O; Ruiz R; Aprile FA; Deierborg T; Venero JL
    Acta Neuropathol; 2023 Jul; 146(1):51-75. PubMed ID: 37202527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A stress-enhanced model for discovery of disease-modifying gene: Ece1-suppresses the toxicity of α-synuclein A30P.
    Chen AY; Tully T
    Neurobiol Dis; 2018 Jun; 114():153-163. PubMed ID: 29524599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease.
    Huang R; Gao Y; Duan Q; Zhang Q; He P; Chen J; Ma G; Wang L; Zhang Y; Nie K; Wang L
    Mol Neurobiol; 2023 Feb; 60(2):979-1003. PubMed ID: 36394710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice.
    Szego ÉM; Gerhardt E; Kermer P; Schulz JB
    Neurobiol Dis; 2012 Jan; 45(1):591-600. PubMed ID: 22001606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression.
    Wang Y; Wang Q; Yu R; Zhang Q; Zhang Z; Li H; Ren C; Yang R; Niu H
    Aging (Albany NY); 2020 Jul; 12(14):14232-14243. PubMed ID: 32706757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity.
    Bido S; Muggeo S; Massimino L; Marzi MJ; Giannelli SG; Melacini E; Nannoni M; Gambarè D; Bellini E; Ordazzo G; Rossi G; Maffezzini C; Iannelli A; Luoni M; Bacigaluppi M; Gregori S; Nicassio F; Broccoli V
    Nat Commun; 2021 Oct; 12(1):6237. PubMed ID: 34716339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.